成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

TargetMol Chemicals Inc.

TargetMol Chemicals Inc.

Main products: Compound Libraries,Noval Small Molecucles,Nature Compounds,Inhibitory Antibodies,Life science Kits

Current Location: HOME >> Product
Product Categories
TargetMol Chemicals Inc.
Country: United States
Tel: +1-781-999-5354
Mobile: +1-00000000000
E-mail: marketing@targetmol.com
QQ:
Skype: Chat Now!
Address: 36?Washington?Street, Wellesley?Hills
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
Product Name MF CAS Details
MCI-225 135991-48-9 Details
N-Me-aminopyrimidinone9 C16H21N3OS 1356834-62-2 Details
2,5-Dihydroxyacetophenone C8H8O3 490-78-8 Details
EIDD-1931 C9H13N3O6 3258-02-4 Details
IQ-3 C20H11N3O3 312538-03-7 Details
Vorolanib C23H26FN5O3 1013920-15-4 Details
SX-682 C19H14BF4N3O4S 1648843-04-2 Details
Tenovin-6 Hydrochloride C25H35ClN4O2S 1011301-29-3 Details
3-AQC C20H21N5O4 201216-42-4 Details
Butoconazole C19H17Cl3N2S 64872-76-0 Details
Cysteine thiol probe C11H12BrNO3S 1947408-74-3 Details
Ripretinib C24H21BrFN5O2 1442472-39-0 Details
Ingliforib C23H24ClN3O5 186392-65-4 Details
ERK1/2 inhibitor 2 C29H31ClFN5O5 2095719-92-7 Details
Levomenol C15H26O 23089-26-1 Details
Metformin C4H11N5 657-24-9 Details
Tetrazole CH2N4 27988-97-2 Details
Belinostat C15H14N2O4S 866323-14-0 Details
THPP-1 C23H21ClN6O3 1257051-63-0 Details
CB1 antagonist 4 C30H25Cl2F3N4OS 1253641-65-4 Details
Raphin1 acetate C10H12Cl2N4O2 2242616-04-0 Details
ILK-IN-3 C10H12N6O 6975-75-3 Details
SC-236 C16H11ClF3N3O2S 170569-86-5 Details
TLR4-IN-C34 C17H27NO9 40592-88-9 Details
3-Phenyl-N-[1-(phenylmethyl)-4-piperidinyl]-tricyclo[3.3.1.13,7]decane-1-carboxamide C29H36N2O 1252187-41-9 Details
RA-9 C19H15N3O5 919091-63-7 Details
BC-DXI-843 C28H26N4O4S2 2421117-98-6 Details
RET V804M-IN-1 C19H16N6O 2414909-94-5 Details
LQZ-7I C20H14F2N4 195822-23-2 Details
Enoximone C12H12N2O2S 77671-31-9 Details
DNQX disodium salt C8H5N4NaO6 1312992-24-7 Details
CNQX disodium C9H5N4NaO4 479347-85-8 Details
VLX600 C17H15N7 327031-55-0 Details
BMS-1001 C35H34N2O7 2113650-03-4 Details
MAZ51 C21H18N2O 163655-37-6 Details
Vonafexor C19H15Cl3N2O5S 1192171-69-9 Details
THIQ C33H41ClN6O2 312637-48-2 Details
Dabrafenib Mesylate C24H24F3N5O5S3 1195768-06-9 Details
eCF506 C26H38N8O3 1914078-41-3 Details
SC-43 C21H13ClF3N3O2 1400989-25-4 Details
Empesertib C29H26FN5O4S 1443763-60-7 Details
PU02 C16H12N4S 313984-77-9 Details
QO-40 C18H11ClF3N3O 1259536-70-3 Details
ZSET1446 C15H12N2O 887603-94-3 Details
UNC1079 C28H42N4O2 1418741-86-2 Details
Dantrolene C14H10N4O5 7261-97-4 Details
TC-I2000 C23H18F4N2O 1159996-20-9 Details
SEP-0372814 C21H19N7 1516895-53-6 Details
Spinorphin C45H64N8O10 137201-62-8 Details
NPS2390 C19H21N3O 226878-01-9 Details
Avelumab 1537032-82-8 Details
Bevacizumab C6638H10160N1720O2108S44 216974-75-3 Details
Pembrolizumab 1374853-91-4 Details
Ipilimumab 477202-00-9 Details
Ustekinumab 815610-63-0 Details
Trastuzumab C10H14N6O5 180288-69-1 Details
Rituximab C6416H9874N1688O1987S44 174722-31-7 Details
Nivolumab 946414-94-4 Details
Cetuximab C107H179N35O36S7 205923-56-4 Details
Vedolizumab 943609-66-3 Details
Alirocumab 1245916-14-6 Details
Alemtuzumab 216503-57-0 Details
Daratumumab 945721-28-8 Details
Denosumab C6404H9912N1724O2004S50 615258-40-7 Details
BENZYLACETONE C10H12O 2550-26-7 Details
Infliximab 170277-31-3 Details
Ofatumumab 679818-59-8 Details
Obinutuzumab 949142-50-1 Details
Matuzumab 339186-68-4 Details
Nimotuzumab 828933-51-3 Details
Evolocumab 1256937-27-5 Details
Panitumumab 339177-26-3 Details
2'-Hydroxyacetophenone C8H8O2 118-93-4 Details
5-Methylfurfural C6H6O2 620-02-0 Details
trans-Benzylideneacetone C10H10O 1896-62-4 Details
Cyclic AMP C10H12N5O6P 60-92-4 Details
Pulegone C10H16O 89-82-7 Details
2-Pentylfuran C9H14O 3777-69-3 Details
Neryl acetate C12H20O2 141-12-8 Details
Omalizumab 242138-07-4 Details
2-Phenylacetaldehyde C8H8O 122-78-1 Details
Dehydroabietic acid C20H28O2 1740-19-8 Details
Masitinib mesylate C29H34N6O4S2 1048007-93-7 Details
AC1903 C19H17N3O 831234-13-0 Details
Vanillic Acid C8H8O4 121-34-6 Details
BMS-345541 hydrochloride C14Cl1H18N5 547757-23-3 Details
Filastatin C18H18ClN3O3 431996-53-1 Details
β-Caryophyllene C15H24 87-44-5 Details
CPYPP C18H13ClN2O2 310460-39-0 Details
IM156 C13H16F3N5O 1422365-93-2 Details
Tyrphostin AG 112 C13H8N4O 144978-82-5 Details
Lenvatinib mesylate C22H23ClN4O7S 857890-39-2 Details
ML382 C18H20N2O4S 1646499-97-9 Details
Adalimumab C6428H9912N1694O1987S46 331731-18-1 Details
SMCC C16H18N2O6 64987-85-5 Details
Ramucirumab 947687-13-0 Details
KN-92 hydrochloride C24H26Cl2N2O3S 1431698-47-3 Details
Atezolizumab 1380723-44-3 Details
m-3M3FBS C16H16F3NO2S 200933-14-8 Details
WYC-210 C18H16N2O3S 2131803-93-3 Details
Product Total: Product Page:
136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256